Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non‐small cell lung cancer
Clinical and Translational Medicine · 2024
DOI: 10.1002/ctm2.70056 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Jie Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Circulating Tumor DNA, Lung Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yunnan Provincial Department of Science and Technology Foundation for Youths, Scientific Research Foundation for Doctor, the First Affiliated Hospital of Kunming Medical University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
- Geneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China.
ORCID-Profile: Xiaobo Chen
Förderung
- Yunnan Provincial Department of Science and Technology Foundation for Youths
- Scientific Research Foundation for Doctor, the First Affiliated Hospital of Kunming Medical University
Zitieren
APA
Tang, J., Tian, Y., Wang, S., Liu, Y., Chen, M., Yang, X., Tong, X., Wang, M., Zhao, Y., Pang, J., Ou, Q., & Chen, X. (2024). Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non‐small cell lung cancer. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70056
Vancouver
Tang J, Tian Y, Wang S, Liu Y, Chen M, Yang X, et al. Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non‐small cell lung cancer. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.70056
BibTeX
@article{Tang2024,
author = {Tang, Jie and Tian, Yingsong and Wang, Song and Liu, Yong and Chen, Manjun and Yang, Xudong and Tong, Xinghe and Wang, Mengtian and Zhao, Yunping and Pang, Jiaohui and Ou, Qiuxiang and Chen, Xiaobo},
title = {Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non‐small cell lung cancer},
journal = {Clinical and Translational Medicine},
year = {2024},
doi = {10.1002/ctm2.70056}
}
EUVIMED